These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 12457269)

  • 1. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
    Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
    Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
    J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
    Raap DK; Garcia F; Muma NA; Wolf WA; Battaglia G; van de Kar LD
    J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
    Serres F; Muma NA; Raap DK; Garcia F; Battaglia G; Van de Kar LD
    J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van de Kar LD
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R390-7. PubMed ID: 14604841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist.
    Li Q; Muma NA; van de Kar LD
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1035-42. PubMed ID: 8930214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins.
    Raap DK; Evans S; Garcia F; Li Q; Muma NA; Wolf WA; Battaglia G; Van De Kar LD
    J Pharmacol Exp Ther; 1999 Jan; 288(1):98-106. PubMed ID: 9862759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors.
    Li Q; Muma NA; Battaglia G; Van de Kar LD
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1581-90. PubMed ID: 9316875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
    Kantor S; Graf M; Anheuer ZE; Bagdy G
    Eur Neuropsychopharmacol; 2001 Feb; 11(1):15-24. PubMed ID: 11226808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.
    Zhang Y; D'Souza D; Raap DK; Garcia F; Battaglia G; Muma NA; Van de Kar LD
    J Neurosci; 2001 Oct; 21(20):7919-27. PubMed ID: 11588165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus.
    Raap DK; DonCarlos L; Garcia F; Muma NA; Wolf WA; Battaglia G; Van de Kar LD
    Neuropharmacology; 2000 Jul; 39(10):1823-32. PubMed ID: 10884563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling.
    Li Q; Sullivan NR; McAllister CE; Van de Kar LD; Muma NA
    Psychoneuroendocrinology; 2013 Jul; 38(7):1145-57. PubMed ID: 23219224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovariectomy-induced increases in hypothalamic serotonin-1A receptor function in rats are prevented by estradiol.
    Raap DK; DonCarlos LL; Garcia F; Zhang Y; Muma NA; Battaglia G; Van de Kar LD
    Neuroendocrinology; 2002 Dec; 76(6):348-56. PubMed ID: 12566942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
    Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
    D'Souza DN; Zhang Y; Damjanoska KJ; Carrasco GA; Sullivan NR; Garcia F; Battaglia G; Doncarlos LL; Muma NA; Van de Kar LD
    Neuroendocrinology; 2004; 80(1):31-41. PubMed ID: 15385710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
    J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus.
    Xu H; Qin S; Carrasco GA; Dai Y; Filardo EJ; Prossnitz ER; Battaglia G; Doncarlos LL; Muma NA
    Neuroscience; 2009 Feb; 158(4):1599-607. PubMed ID: 19095043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.